Viewing SEC Facts Units
Company Name:
NeuroSense Therapeutics Ltd.
CIK:
1875091
Start Filing Date:
2022-01-01
End Filing Date:
2022-06-30
ACCN:
0001213900-23-003794
Value:
$ 11,294,701
Value Error:
$ None
Created By:
Date Filed:
2023-01-19
FY:
2022
Fiscal Period:
Q2
Frame:
CY2021
Type:
ifrs-full
Form:
6-K/A
Units:
shares